Silex Systems Limited

A.C.N. 003 372 067

Level 8, Suite 8.03

56 Clarence Street

Sydney NSW 2000 Australia

PO Box 364

Sydney NSW 2001

Tel: + 61 2 9704 8888

Fax: +61 2 9279 1051 www.silex.com.au

Full Year Financial Results - Investor Conference Call Notification

Silex Systems Limited (ASX: SLX) (OTCQX: SILXY) will release its financial results for the year ended 30th June 2014 on Wednesday, 27th August 2014.

Investors are invited to join a conference call to be hosted by Dr Michael Goldsworthy, CEO/Managing Director at 12.00pm (AEST) on Wednesday, 27th August 2014. An update on the company's current activities will also be provided during the call.

Conference ID: 85486725 Toll free access numbers:

Australia

1800 123 296

New Zealand

0800 452 782

China

4001 203 085

Hong Kong

800 908 865

India

1800 3010 6141

Japan

0120 985 190

Singapore

800 616 2288

United Kingdom

0808 234 0757

United States

1855 293 1544

Canada

1855 561 6766

For all other international locations dial*:

*charges apply

+61 2 8038 5221

Further Information

Further information on the Company's activities can be found on the Silex website: www.silex.com.au or by contacting the persons listed below.

Company

Media and Investor Relations

Michael Goldsworthy, CEO, or

Julie Ducie, CFO / Company Secretary

+61 2 9704 8888

Media: Ben Oliver, Buchan Consulting,

+61 3 9866 4722, +61(0)402 242 9825

Investor: Jane Lowe, Buchan Consulting,

+61 2 9237 2800

1 | P a g e

Forward Looking Statements and Business Risks:

Silex Systems is a research and development Company whose assets are its proprietary rights in various technologies, including, but not limited to, the SILEX technology, Solar Systems technology and business, Translucent technology and ChronoLogic technology. Several of the Company's technologies are in the development stage and have not been commercially deployed, and therefore are high-risk. Accordingly, the statements in this announcement regarding the future of the Company's technologies and commercial prospects are forward looking and actual results could be materially different from those expressed or implied by such forward looking statements as a result of various risk factors.
Some risk factors that could affect future results and commercial prospects include, but are not limited to: results from the SILEX uranium enrichment commercialisation program; the demand for enriched uranium; the risks associated with the development of Solar Systems technology and related marketing activities; the outcomes of the Company's interests in the development of various semiconductor, photonics, instrumentation and alternative energy technologies; the time taken to develop various technologies; the development of competing technologies; the potential for third party claims against the Company's ownership of Intellectual Property associated with its numerous technologies; the potential impact of government regulations or policies; and the outcomes of various commercialisation strategies undertaken by the Company.

2 | P a g e

distributed by